Evidence map›Paper›PMID 32707221›Full record

ArticleKidney international2021

A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death.

T Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb, Vernon M Chinchilli, Kathleen D Liu, Steven G Coca, Amit X Garg, Chi-Yuan Hsu, Edward D Siew, Mark M Wurfel and 7 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Kidney international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07626268 (CONNECT-AKI), which is not on this map. Cited by 91 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 6 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07626268 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

CONNECT-AKI: COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury - A Pilot Randomized Controlled Trial

TypeinterventionalSponsorNorthwell HealthRan2026 to 2027Enrolled160ConditionsAcute Kidney Injury, Acute Kidney Injury (AKI)ArmsAKI Discharge Summary Template, Chat-Based Educational Messaging Program
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 6 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Pooled it
  4. Pooled it
  5. Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Pooled it
  6. Guideline
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Observational

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

T Alp IkizlerDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Jonathan HimmelfarbKidney Research Institute, Department of Medicine, University of Washington, Seattle, Washington, USA.
Vernon M ChinchilliDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Kathleen D LiuDivision of Nephrology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California, USA.
Steven G CocaDivision of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Amit X GargDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.
Chi-Yuan HsuDivision of Nephrology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California, USA.
Edward D SiewDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mark M WurfelDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington, USA.
Lorraine B WareDivision of Allergy, Pulmonary and Critical Care, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Georgia Brown FaulknerDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Thida C TanDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
James S KaufmanRenal Section, Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York, USA.
Paul L KimmelDivision of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Alan S GoDivision of Nephrology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, California, USA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA; Departments of Medicine (Nephrology), Health Research and Policy, Stanford University, Stanford, California, USA. Electronic address: Alan.S.Go@kp.org.
ASSESS-AKI Study Investigators
University of California, San Francisco · USVanderbilt University Medical Center · USUniversity of Washington · USPennsylvania State University · USIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USVA NY Harbor Healthcare System · USWestern University · CAKaiser Permanente · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, IYENGAR, SRINIVAS RAVI V · 2017 to 2021
$21.0M
Study of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
Data Coordinating Center for the Natural History of AKI ConsortiumU01DK082183 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHINCHILLI, VERNON M · 2008 to 2018
$9.7M
Genetic Determinants of Outcomes in Acute Kidney InjuryU01DK084012 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, WURFEL, MARK M · 2010 to 2019
$6.2M
Progression of Acute Kidney Injury to Chronic Kidney DiseaseU01DK082185 · NIDDK · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2008 to 2017
$5.1M
Impact of Acute Kidney Injury on Kidney Disease ProgressionU01DK082192 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI IKIZLER, TALAT ALP · 2008 to 2018
$5.0M
Prospective Evaluation of Acute Kidney Injury (PEAK) CohotU01DK082223 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2008 to 2018
$4.0M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
NCATS NIH HHS UG3 TR002158NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024131NHLBI NIH HHS K24 HL103836NHLBI NIH HHS R01 HL085757NHLBI NIH HHS R01 HL135849NIDDK NIH HHS K23 DK088964NIDDK NIH HHS K24 DK092291NIDDK NIH HHS K24 DK113381NIDDK NIH HHS R01 DK098233NIDDK NIH HHS R01 DK101507NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK082183NIDDK NIH HHS U01 DK082185NIDDK NIH HHS U01 DK082192NIDDK NIH HHS U01 DK082223NIDDK NIH HHS U01 DK084012NIDDK NIH HHS U01 DK099923NIDDK NIH HHS U01 DK106962NIDDK NIH HHS U01 DK114866NIDDK NIH HHS U24 DK114886NIDDK NIH HHS U2C DK114886NIDDK NIH HHS UH3 DK114908
6 · The paper itself

Abstract

Acute kidney injury (AKI) has been reported to be associated with excess risks of death, kidney disease progression and cardiovascular events although previous studies have important limitations. To further examine this, we prospectively studied adults from four clinical centers surviving three months and more after hospitalization with or without AKI who were matched on center, pre-admission CKD status, and an integrated priority score based on age, prior cardiovascular disease or diabetes mellitus, preadmission estimated glomerular filtration rate (eGFR) and treatment in the intensive care unit during the index hospitalization between December 2009-February 2015, with follow-up through November 2018. All participants had assessments of kidney function before (eGFR) and at three months and annually (eGFR and proteinuria) after the index hospitalization. Associations of AKI with outcomes were examined after accounting for pre-admission and three-month post-discharge factors. Among 769 AKI (73% Stage 1, 14% Stage 2, 13% Stage 3) and 769 matched non-AKI adults, AKI was associated with higher adjusted rates of incident CKD (adjusted hazard ratio 3.98, 95% confidence interval 2.51-6.31), CKD progression (2.37,1.28-4.39), heart failure events (1.68, 1.22-2.31) and all-cause death (1.78, 1.24-2.56). AKI was not associated with major atherosclerotic cardiovascular events in multivariable analysis (0.95, 0.70-1.28). After accounting for degree of kidney function recovery and proteinuria at three months after discharge, the associations of AKI with heart failure (1.13, 0.80-1.61) and death (1.29, 0.84-1.98) were attenuated and no longer significant. Thus, assessing kidney function recovery and proteinuria status three months after AKI provides important prognostic information for long-term clinical outcomes.

Indexed as

Acute Kidney InjuryCardiovascular DiseasesAdultAftercareGlomerular Filtration RateHumansKidneyPatient DischargeProspective StudiesRisk Factorsacute kidney injuryacute renal failurecardiovascular diseasechronic kidney diseaseheart failuremortality

Identifiers

PMID32707221
PMCPMC7374148
OpenAlexW3043938955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.